Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Holdings Lowered by Legal & General Group Plc
Legal & General Group Plc cut its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.1% during the 4th quarter, HoldingsChannel reports. The firm owned 98,732 shares of the biopharmaceutical company’s stock after selling 3,180 shares during the quarter. Legal & General Group Plc’s holdings in Ultragenyx Pharmaceutical were worth $4,154,000 as of […]
Legal & General Group Plc cut its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 3.1% during the 4th quarter, HoldingsChannel reports. The firm owned 98,732 shares of the biopharmaceutical company’s stock after selling 3,180 shares during the quarter. Legal & General Group Plc’s holdings in Ultragenyx Pharmaceutical were worth $4,154,000 as of […]
